Nursing homes fined nearly $1 million over state vaccination rules
By
Danielle Brown
Nov 23, 2021
Nursing home stakeholders in Connecticut are calling on the state to take a deeper look into facilities’ compliance with its COVID-19 vaccine mandate and reporting requirements in response to nearly...
More oversight of private equity nursing homes warranted, study finds
By
Danielle Brown
Nov 23, 2021
The public push for more oversight of private equity nursing homes may be warranted, according to a new JAMA Network study that found for-profit facilities were associated with higher costs and more hospital...
Early Alzheimer’s diagnosis may unintentionally hamper social engagement
By
Alicia Lasek
Nov 23, 2021
Clinicians should identify strategies to alleviate the social impacts of dementia diagnoses and encourage patients to mobilize informal support networks, researchers say.
AHA’s new heart-health dietary advice highlights personal patterns, style
By
Alicia Lasek
Nov 23, 2021
The emphasis is now on dietary patterns, not specific foods or nutrients, the lead author says. “And it’s not just about what people shouldn’t be eating.”
Best practices for antibiotic stewardship & infection control in long-term care
By
Oliver Schacht
Nov 22, 2021
Each year, the Centers for Disease Control and Prevention recognizes U.S. Antibiotic Awareness Week November 18-24, highlighting the importance of appropriate antibiotic use in fighting the threat of drug...
Facility-led discharges draw watchdog’s scrutiny
By
Danielle Brown
Nov 22, 2021
A government watchdog is urging the Centers for Medicare & Medicaid Services to keep a more watchful eye on facility-initiated discharges after finding nursing homes rarely complied with federal requirements...
Phase 4 PRF award timeline updated
By
Danielle Brown
Nov 22, 2021
Long-term care operators who have applied for Phase 4 Provider Relief or rural COVID-19 relief payments won’t receive the awards until mid-December, after a distribution delay was announced by the Health...
Ethical considerations explored for aducanumab in Alzheimer disease
Nov 19, 2021
Grounds insufficient to offer aducanumab for moderate, advanced Alzheimer dementia or patients without biomarker evidence of brain ß-amyloid
AHA: Oral milvexian promising for prevention of VTE
Nov 19, 2021
In patients undergoing knee arthroplasty, postoperative incidence of venous thromboembolism lower with milvexian versus enoxaparin
Trial begins of nasal vaccine for Alzheimer disease
Nov 18, 2021
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health